Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIR219A2 Host Gene (MIR219A2HG)
- Target
- MIR219A2HG
- Molecular classification
- Other (Long non-coding RNA gene), MicroRNA host gene (processes to microRNA miR-219a-2)
01
Overview
MIR219A2 Host Gene (MIR219A2HG) is a long non-coding RNA gene that encodes the precursor transcript for microRNA miR-219a-2. It does not code for a protein and is not a traditional therapeutic target such as a receptor or enzyme. miR-219a-2 produced from this gene is involved in post-transcriptional regulation, typically by binding and silencing target mRNAs, affecting their stability and translation. The biological roles of MIR219A2HG are primarily through its product, miR-219a-2, which may have regulatory functions in development and disease. No approved drugs directly target MIR219A2HG, and it is not considered a clinical biomarker by itself.
- Other names
- MIR219A2 Host GeneMIR219A2HG
02
Mechanism of action
None established for MIR219A2HG as a direct drug target. Mechanisms for miRNA-related therapeutics often involve modulating miRNA levels or function.
03
Biological functions
Hosts miR-219a-2, a microRNA involved in post-transcriptional regulation of gene expressionMay participate in RNA silencing, affecting mRNA stability and translationCould participate in regulatory non-coding RNA networks
04
Disease associations
Other (Potential role via miR-219a-2 in disorders where miR-219 is involved; not directly established as an independent disease gene)
05
Safety considerations
No specific therapeutic safety concerns are recognized for MIR219A2HG, as it is not a direct clinical target.For RNA-targeted therapies, off-target effects and delivery remain general challenges.
06
Interacting drugs
None known specific to MIR219A2HG. No approved drugs are reported to directly target this host gene.
07
Biomarkers
Circulating miR-219 has been explored as a biomarker in various neurological disorders, but not MIR219A2HG itself.
Beyond the preview
Go deeper on MIR219A2 Host Gene (MIR219A2HG).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MIR219A2 Host Gene (MIR219A2HG).